Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This drug has an extremely low addiction and dependency potential, therefore classifying it as a Schedule IV drug here in Nashville
Fujita, H
For these patients, an individualised risk assessment before or shortly after starting treatment is worthwhile
Novel biomarkers such as, kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) can be good indicators in the assessment of renal damages [54]
US$ 29.50
US$ 26.95
US$ 29.63
US$ 29.54
US$ 20.48
US$ 20.85
US$ 28.54
